| Variable
| Values |
| Age, (range) yrs | 67,4 ± 2,1 (45–88) | Male, n, % | 16, (57,1) | Admission diagnosis, n | | Pulmonary Infection, RR | 15 | Pulmonary edema, CHF | 5 | Complicated surgery | 4 | SAH/ICH | 2 | Abdominal sepsis | 1 | Trauma, head injury | 1 | Type, n | | Medical | 24 | Surgical | 4 | APACHE II | 22,2 ± 0,9 | Predicted death rate, % | 43,1 | SOFA | 10,1 ± 0,6 | Outcome (mortality %) | 10/28 (35,7) | MV duration, days | 24,5 ± 5,1 | ICU LOS (median), days | 31,6 ± 5,7 (21) | Fever, >38.2°C | 12/28 | Low-dose steroids, n | 17/28 | Shock, nor-adrenaline, n | 27/28 | LMWH, n | 17/28 | Fondaparinux (Arixtra), n | 9/28 | Transfusions, n, (mean) | 18/28 (2,9 ± 0,7 units) | Phenytoin (Epanutin), n | 3/28 | Albumin, g/dL | 3,1 ± 0,1 (3,7–5,2) | Corrected calcium, mg/dL | 8,2 ± 0,3 (8,5–10,5) | Phosphorus, mg/dL | 3,4 ± 0,2 (2,5–4,8) | Alkaline phosphatase, U/L | 120,0 ± 1,4 (42–141) | Urea, mg/dL | 53,9 ± 5,3 (10–50) | AST (SGOT), IU/dL | 44,4 ± 9,8 (9–36) | ALT (SGPT), IU/dL | 68,9 ± 28,9 (20–28) | WBC, /mm3 | 11,087 ± 1,415 | Creatinine, mg/dL | 1,1 ± 0.7 (0,6–1,4) | CRP, mg/dL | 108,4 ± 20,1 (<3,16) | Food supplementation, n | | Enteral | 28/28 | Parenteral | 2 | Both | 2/28 | Micronutrients | 28/28 | Vitamins | 28/28 |
|
|
In parenthesis data represents range, n, percentages, or normal values. RR: respiratory failure, ICH: intracerebral hemorrhage, SAH: subarachnoid hemorrhage, CHF: congestive heart failure, LMWH: low molecular weight heparin, CRP: c-reactive protein, ICU: intensive care medicine, WBC: white blood cell, APACHE II: Acute Physiology And Chronic Health Evaluation, SOFA: Sequential Organ Failure Assessment, AST: Aspartate Aminotransferase, and ALT: Alanine Aminotransferase.
|